Funded Tech Companies
Centivax
Centivax is a biopharmaceutical tech company, based in San Francisco. Venture capital investment was provided by NFX, Kendall Capital Partners and Bold Capital Partners.
Company Overview
Company Name
Centivax
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
329 Oyster Point Boulevard South
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Developer of a therapeutics and clinical-stage company intended to treat and eradicate rapidly mutating pathogens. The company applies its computational immune engineering expertise to develop therapeutic monoclonal antibodies against a variety of targets, it builds a panel of neutralizing antibodies against SARS-CoV-2, enabling people to be safe from health issues with the help of vaccinations.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/9/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacob Glanville
Chief Operating Officer
David Tsao
Chief Technical Officer
Nicholas Bayless
Co-Founder
Sawsan Youssef
Company Investors
- NFX
- Kendall Capital Partners
- Bold Capital Partners
- Amplify Partners
- Private Investors (Steve Jurvetson)
- Global Health Investment Corporation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs